Naperville, IL -- (SBWIRE) -- 09/21/2012 -- RaQualia Pharma Inc. - Product Pipeline Review - 2012 provides data on the RaQualia Pharma Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
- RaQualia Pharma Inc. - Brief RaQualia Pharma Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of RaQualia Pharma Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of RaQualia Pharma Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the RaQualia Pharma Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate RaQualia Pharma Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of RaQualia Pharma Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the RaQualia Pharma Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with RaQualia Pharma Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of RaQualia Pharma Inc. and identify potential opportunities in those areas.
Current R&D Portfolio of RaQualia Pharma Inc.; RaQualia Pharma Inc. - Key Therapeutics; RaQualia Pharma Inc. - Pipeline Overview and Promising Molecules; RaQualia Pharma Inc. - News; RaQualia Pharma Inc. - Latest Updates; RaQualia Pharma Inc. - Pipeline; RaQualia Pharma Inc. - Discontinued/Dormant Projects
To view table of contents for this market report please visit:
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)